Action planning test for teens with IBD
Part of Digestive system clinical trials.
This study tests if a planning tool helps teenagers with Crohn's disease or ulcerative colitis manage their condition. It's for patients aged 13 to 19 who have had their diagnosis for at least 3 months and are seen at UNC.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 13 and 19 years old.
- You have been diagnosed with Crohn's disease, ulcerative colitis, or indeterminate colitis for at least 3 months.
- You receive care at UNC and have had at least one visit there in the past year.
- You speak English or Spanish.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if a mobile app can help manage your inflammatory bowel disease (IBD) from home. You may be eligible if you have IBD that has been active in the last two years and you are between 18 and 75 years old.
This study checks whether a personalized tool can estimate someone’s risk for Crohn’s disease before symptoms start. It may help families learn early risk and decide on next steps sooner.
This trial tests a self-management program for people with active Crohn's disease or ulcerative colitis. It aims to improve quality of life by helping you better manage your condition.
This study tests whether a virtual program can help teens with IBD who also have depression or anxiety. It looks at how stress affects the body through heart rate patterns and aims to improve both gut and emotional health.
This study is developing a new questionnaire to measure how well people with inflammatory bowel disease (IBD) manage their own care. If you join, you will help researchers create a tool that could improve support for others with IBD.
This study aims to improve care and reduce health gaps for people with inflammatory bowel disease using text-message surveys to track symptoms and guide better disease management.
Hear when a new Inflammatory Bowel Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.